Publications by authors named "Daisy Yang"

Claim this Profile
N
Non-optimal treatment with first tyrosine kinase inhibitor and associated economic burden in chronic myeloid leukemia.
Vamsi Kota, David Wei, Daisy Yang, Hela Romdhani, Dominick Latremouille-Viau

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States.
Jason Shafrin, Kejal Jadhav, Cheryl Warren, Sabiha Quddus, Nadine Zawadzki, Daisy Yang

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia.
Ehab L Atallah, Islam Sadek, David Wei, Dominick Latremouille-Viau, Carmine Rossi, Daisy Yang

Leuk Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Patient-Reported Outcome Measures in Clinical Studies of Chronic Myeloid Leukemia: A Scoping Literature Review.
Kathryn E Flynn, Lovneet Saini, Aditi Kataria, Kejal Jadhav, Daisy Yang

Curr Hematol Malig Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia.
Kathryn E Flynn, Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Daisy Yang

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study.
Kathryn E Flynn, Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Daisy Yang

J Natl Compr Canc Netw· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trial.
Ehab L Atallah, Michael J Mauro, Koji Sasaki, Moshe Y Levy, Paul Koller, Daisy Yang

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Fabrication of Superhydrophobic Virtual Walls for Microfluidic Gas Extraction and Sensing.
Wojciech Raj, Daisy Yang, Craig Priest

Micromachines (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Antimicrobial Stewardship on Physician Practice in a Geriatric Facility.
Nina Kassett, Rosalind Sham, Rosanne Aleong, Daisy Yang, Michael Kirzner

Can J Hosp Pharm· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid organ transplant patients: are there opportunities for antimicrobial stewardship?
Miranda So, Daisy Yu Yang, Chaim Bell, Atul Humar, Andrew Morris

Clin Transplant· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.
Emily Wang, Dimitrios Farmakiotis, Daisy Yang, Deborah A McCue, Hagop M Kantarjian

J Antimicrob Chemother· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Khanh Vu, Nhiem V Luong, Julie Hubbard, Ali Zalpour, Stefan Faderl, Daisy Yang

Cancer Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucarpidase Intervention for Delayed Methotrexate Clearance.
Jennifer L Cavone, Daisy Yang, Alice Wang

Ann Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation syndrome in patients with acute promyelocytic leukemia.
Jane E Rogers, Daisy Yang

J Oncol Pharm Pract· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
Huyentran Tran, Daisy Yang

Ann Pharmacother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
Kaci Wilhelm, Daisy Yang

J Oncol Pharm Pract· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute promyelocytic leukemia during pregnancy.
Daisy Yang, Lindsay Hladnik

Pharmacotherapy· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis